generics

Mylan, Biocon help market generic insulin drugs

Mylan, Biocon help market generic insulin drugs

Yahoo/AP

Teva warns could face legal costs of $2.07 bln

Teva warns could face legal costs of $2.07 bln

Reuters

FDA approves generic version of cancer drug Doxil

FDA approves generic version of cancer drug Doxil

Reuters

American consumers approach court to consider recall of Ranbaxy's generic drug Lipitor

American consumers approach court to consider recall of Ranbaxy's generic drug Lipitor

Economic Times, India

AstraZeneca Forecasts Lower Profit Amid Generic Pressure

AstraZeneca Forecasts Lower Profit Amid Generic Pressure

Bloomberg

Pfizer Will Consider Split of Drug Units, CEO Read Says

Pfizer Will Consider Split of Drug Units, CEO Read Says

Bloomberg

Generic Launch at Dr. Reddy's

Generic Launch at Dr. Reddy's

Yahoo/Zacks

AbbVie Sues Generic Drugmaker Sun Over Zemplar Patent

AbbVie Sues Generic Drugmaker Sun Over Zemplar Patent

BusinessWeek

1 Undervalued Generic Producer and 1 Peer Stock With Momentum

1 Undervalued Generic Producer and 1 Peer Stock With Momentum

Motley Fool

Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug

Par Pharmaceutical Sued by Horizon Over Generic Duexis Drug

Bloomberg